Your browser doesn't support javascript.
loading
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives.
Middleton, Mark R; Hoeller, Christoph; Michielin, Olivier; Robert, Caroline; Caramella, Caroline; Öhrling, Katarina; Hauschild, Axel.
Afiliação
  • Middleton MR; University of Oxford Department of Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK. mark.middleton@oncology.ox.ac.uk.
  • Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Robert C; Department of Oncology, Gustave Roussy Cancer Campus, Villejuif, and Paris-Saclay University, Orsay, France.
  • Caramella C; Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Öhrling K; Amgen Europe GmbH, Rotkreuz, Switzerland.
  • Hauschild A; Department of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein, Kiel, Germany.
Br J Cancer ; 123(6): 885-897, 2020 09.
Article em En | MEDLINE | ID: mdl-32713938
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Imunoterapia / Melanoma Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Imunoterapia / Melanoma Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido